Mechanism of action, clinical effectiveness, and optimal therapeutic range

被引：358
|
作者：
Hirsh, J [1 ]
Dalen, JE [1 ]
Anderson, DR [1 ]
Poller, L [1 ]
Bussey, H [1 ]
Ansell, J [1 ]
Deykin, D [1 ]
Brandt, JT [1 ]
机构：
[1] Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada
来源：
CHEST | 1998年 / 114卷 / 05期
关键词：
D O I：
10.1378/chest.114.5_Supplement.445S
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：445S / 469S
页数：25
相关论文
共 50 条
  • [1] MECHANISM OF ACTION, CLINICAL EFFECTIVENESS, AND OPTIMAL THERAPEUTIC RANGE
    HIRSH, J
    DALEN, JE
    DEYKIN, D
    POLLER, L
    BUSSEY, H
    CHEST, 1995, 108 (04) : S231 - S246
  • [2] Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
    Hirsh, J
    Dalen, JE
    Anderson, DR
    Poller, L
    Bussey, H
    Ansell, J
    Deykin, D
    CHEST, 2001, 119 (01) : 8S - 21S
  • [3] ORAL ANTICOAGULANTS - MECHANISM OF ACTION, CLINICAL EFFECTIVENESS, AND OPTIMAL THERAPEUTIC RANGE
    HIRSH, J
    DALEN, JE
    DEYKIN, D
    POLLER, L
    CHEST, 1992, 102 (04) : S312 - S326
  • [4] MECHANISM OF ACTION OF CARDIOVASCULAR DRUGS AND THEIR CLINICAL EFFECTIVENESS
    TAKENAKA, F
    JAPANESE HEART JOURNAL, 1966, 7 (01): : 1 - &
  • [5] Phosphogliv: Mechanism of therapeutic action and clinical efficiency.
    Archakov, AI
    Selzovskyi, AP
    Lisov, VI
    Tsyganov, DI
    Knyazhev, VA
    Ipatova, OM
    Torkhovskaya, TI
    VOPROSY MEDITSINSKOI KHIMII, 2002, 48 (02): : 139 - 153
  • [6] Therapeutic Monitoring of Lacosamide in Japanese Patients With Epilepsy: Clinical Response, Tolerability, and Optimal Therapeutic Range
    Yamamoto, Yoshiaki
    Terada, Kiyohito
    Araki, Yasukiyo
    Fukushima, Yutaro
    Imai, Katsumi
    Kagawa, Yoshiyuki
    Takahashi, Yukitoshi
    THERAPEUTIC DRUG MONITORING, 2020, 42 (05) : 754 - 759
  • [7] STREPTOKINASE - REVIEW OF ITS CLINICAL PHARMACOLOGY, MECHANISM OF ACTION AND THERAPEUTIC USES
    BROGDEN, RN
    SPEIGHT, TM
    AVERY, GS
    DRUGS, 1973, 5 (5-6) : 357 - 445
  • [8] OPTIMAL THERAPEUTIC RANGE FOR ORAL ANTICOAGULANTS
    HIRSH, J
    POLLER, L
    DEYKIN, D
    LEVINE, M
    DALEN, JE
    CHEST, 1989, 95 (02) : S5 - S11
  • [9] Establishing an optimal therapeutic range for coumarins
    Bellelli, G
    Rozzini, R
    Trabucchi, M
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (20) : 2282 - 2282
  • [10] FROM CLINICAL EFFECTIVENESS TO ELUCIDATION OF THE MECHANISM OF ACTION - 20 YEARS OF INVESTIGATION ON METOCLOPRAMIDE
    QUIVY, F
    PATHOLOGIE BIOLOGIE, 1987, 35 (07): : 1099 - 1100
12345